Enterprise stents for the treatment of symptomatic non-acute intracranial artery stenosis disease: safety and efficiency evaluation

References

• Wang Y, Zhao X, Liu L, et al. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese intracranial atherosclerosis (CICAS) study. Stroke. 2014;45(3):663–669. doi: 10.1161/STROKEAHA.113.003508
   PubMed Web of Science ®Google Scholar
• Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113(4):555–563. doi: 10.1161/CIRCULATIONAHA.105.578229
   PubMed Web of Science ®Google Scholar
• Tang L, Wang L, Li C, et al. Treatment of basilar artery stenosis with an Apollo balloon-expandable stent: a single-centre experience with 61 consecutive cases. Acta Neurol Belg. 2021;121(6):1423–1427. doi: 10.1007/s13760-020-01311-8
   PubMed Web of Science ®Google Scholar
• Derdeyn CP, Chimowitz MI, Lynn MJ, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014;383(9914):333–341. doi: 10.1016/S0140-6736(13)62038-3
   PubMed Web of Science ®Google Scholar
• King B, Vaziri S, Singla A, et al. Clinical and angiographic outcomes after stent-assisted coiling of cerebral aneurysms with enterprise and neuroform stents: a comparative analysis of the literature. J Neurointerv Surg. 2015;7(12):905–909. doi: 10.1136/neurintsurg-2014-011457
   PubMed Web of Science ®Google Scholar
• Sun B, Xu C, Wu P, et al. Intracranial angioplasty with enterprise stent for intracranial atherosclerotic stenosis: a single-center experience and a Systematic Review. Biomed Res Int. 2021;2021:6645500. doi: 10.1155/2021/6645500
   PubMed Web of Science ®Google Scholar
• Feigin VL, Stark BA, Johnson CO, et al. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol. 2021;20(10):795–820. doi: 10.1016/S1474-4422(21)00252-0
   PubMed Web of Science ®Google Scholar
• Gutierrez J, Turan TN, Hoh BL, et al. Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2022;21(4):355–368. doi: 10.1016/S1474-4422(21)00376-8
   PubMed Web of Science ®Google Scholar
• Gorelick PB, Wong KS, Bae HJ, et al. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke. 2008;39(8):2396–2399. doi: 10.1161/STROKEAHA.107.505776
   PubMed Web of Science ®Google Scholar
• De Silva DA, Woon FP, Lee MP, et al. South Asian patients with ischemic stroke: intracranial large arteries are the predominant site of disease. Stroke. 2007;38(9):2592–2594. doi: 10.1161/STROKEAHA.107.484584
   PubMed Web of Science ®Google Scholar
• Gutierrez J, Khasiyev F, Liu M, et al. Determinants and outcomes of asymptomatic intracranial atherosclerotic stenosis. J Am Coll Cardiol. 2021;78(6):562–571. doi: 10.1016/j.jacc.2021.05.041
   PubMed Web of Science ®Google Scholar
• Liu L, Wang D, Wong KS, et al. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke. 2011;42(12):3651–3654. doi: 10.1161/STROKEAHA.111.635755
   PubMed Web of Science ®Google Scholar
• Pan Y, Jing J, Cai X, et al. Prevalence and vascular distribution of multiterritorial atherosclerosis among community-dwelling adults in Southeast China. JAMA Netw Open. 2022;5(6):e2218307. doi: 10.1001/jamanetworkopen.2022.18307
   PubMed Web of Science ®Google Scholar
• Flusty B, De Havenon A, Prabhakaran S, et al. Intracranial atherosclerosis treatment: past, present, and future. Stroke. 2020;51(3):e49–e53. doi: 10.1161/STROKEAHA.119.028528
   PubMed Web of Science ®Google Scholar
• Barnard ZR, Alexander MJ. Update in the treatment of intracranial atherosclerotic disease. Stroke Vasc Neurol. 2020;5(1):59–64. doi: 10.1136/svn-2019-000279
   PubMedGoogle Scholar
• Zaidat OO, Fitzsimmons BF, Woodward BK, et al. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA. 2015;313(12):1240–1248. doi: 10.1001/jama.2015.1693
   PubMed Web of Science ®Google Scholar
• Barnard ZR, Alexander MJ. Device profile of the wingspan stent system for the treatment of intracranial atherosclerotic disease: overview of its safety and efficacy. Expert Rev Med Devices. 2020;17(3):167–171. doi: 10.1080/17434440.2020.1732813
   PubMed Web of Science ®Google Scholar
• Alexander MJ, Zauner A, Chaloupka JC, et al. WEAVE trial: final results in 152 on-label patients. Stroke. 2019;50(4):889–894. doi: 10.1161/STROKEAHA.118.023996
   PubMed Web of Science ®Google Scholar
• Gao P, Wang T, Wang D, et al. Effect of stenting plus medical therapy vs medical therapy alone on risk of stroke and death in patients with symptomatic intracranial stenosis: the CASSISS randomized clinical trial. JAMA. 2022;328(6):534–542. doi: 10.1001/jama.2022.12000
   PubMed Web of Science ®Google Scholar
• Cui R, Yan L, Kang K, et al. Long-term outcome of enterprise stenting for symptomatic ICAS in a high-volume stroke center. Front Neurol. 2021;12:672662. doi: 10.3389/fneur.2021.672662
   PubMed Web of Science ®Google Scholar
• Wang X, Wang Z, Wang C, et al. Application of the enterprise stent in atherosclerotic intracranial arterial stenosis: a series of 60 cases. Turk Neurosurg. 2016;26(1):69–76. doi: 10.5137/1019-5149.JTN.13350-14.1
   PubMed Web of Science ®Google Scholar
• Lee KY, Chen DY-T, Hsu HL, et al. Undersized angioplasty and stenting of symptomatic intracranial tight stenosis with enterprise: evaluation of clinical and vascular outcome. Interv Neuroradiol. 2016;22(2):187–195. doi: 10.1177/1591019915609165
   PubMed Web of Science ®Google Scholar
• Vajda Z, Schmid E, Güthe T, et al. The modified Bose method for the endovascular treatment of intracranial atherosclerotic arterial stenoses using the enterprise stent. Neurosurgery. 2012;70(1):91–101. discussion 101. doi: 10.1227/NEU.0b013e31822dff0f
   PubMed Web of Science ®Google Scholar
• Zhang K, Li TX, Wang ZL, et al. Factors affecting in-stent restenosis after angioplasty with the enterprise stent for intracranial atherosclerotic diseases. Sci Rep. 2021;11(1):10479. doi: 10.1038/s41598-021-89670-x
   PubMed Web of Science ®Google Scholar
• Jia B, Zhang X, Ma N, et al. Comparison of drug-eluting stent with bare-metal stent in patients with symptomatic high-grade intracranial atherosclerotic stenosis: a randomized clinical trial. JAMA Neurol. 2022;79(2):176–184. doi: 10.1001/jamaneurol.2021.4804
   PubMed Web of Science ®Google Scholar
• Gao F, Guo X, Han J, et al. Endovascular recanalization for symptomatic non-acute middle cerebral artery occlusion: proposal of a new angiographic classification. J Neurointerv Surg. 2021;13(10):900–905. doi: 10.1136/neurintsurg-2020-016692
   PubMed Web of Science ®Google Scholar
• Gao F, Sun X, Guo X, et al. Endovascular recanalization of symptomatic nonacute intracranial internal carotid artery occlusion: proposal of a new angiographic classification. AJNR Am J Neuroradiol. 2021;42(2):299–305. doi: 10.3174/ajnr.A6928
   PubMed Web of Science ®Google Scholar
• Song X, Qiu H, Wang S, et al. Hemodynamic and geometric risk factors for In-stent restenosis in patients with intracranial atherosclerotic stenosis. Oxid Med Cell Longev. 2022;2022:6951302. doi: 10.1155/2022/6951302
   PubMed Web of Science ®Google Scholar
• Alurkar A, Karanam LS, Oak S, et al. Role of balloon-expandable stents in intracranial atherosclerotic disease in a series of 182 patients. Stroke. 2013;44(7):2000–2003. doi: 10.1161/STROKEAHA.113.001446
   PubMed Web of Science ®Google Scholar
• Li J, Zhao ZW, Gao GD, et al. Wingspan stent for high-grade symptomatic vertebrobasilar artery atherosclerotic stenosis. Cardiovasc Intervent Radiol. 2012;35(2):268–278. doi: 10.1007/s00270-011-0163-5
   PubMed Web of Science ®Google Scholar
• Liu W, Cheon J, Thomas SA. Interventions on mealtime difficulties in older adults with dementia: a systematic review. Int J Nurs Stud. 2014;51(1):14–27. doi: 10.1016/j.ijnurstu.2012.12.021
   PubMed Web of Science ®Google Scholar
• Peng G, Zhang Y, Miao Z. Incidence and risk factors of In-stent restenosis for symptomatic intracranial atherosclerotic stenosis: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 2020;41(8):1447–1452. doi: 10.3174/ajnr.A6689
   PubMed Web of Science ®Google Scholar
• Jin M, Fu X, Wei Y, et al. Higher risk of recurrent ischemic events in patients with intracranial in-stent restenosis. Stroke. 2013;44(11):2990–2994. doi: 10.1161/STROKEAHA.113.001824
   PubMed Web of Science ®Google Scholar